Dr. Akaolisa Samuel Eziokwu, MD

Dr. Eziokwu practices at Adena Regional Medical Center in Chillicothe, Ohio, part of Adena Health System.

Dr. Eziokwu's NPI, 1265884100, was assigned on July 4, 2016. Dr. Eziokwu holds Ohio license 35.134475.

Dr. Eziokwu's primary practice is Adena Regional Medical Center, at 272 Hospital Road, Chillicothe, OH 45601 in Ross County. The practice phone is (740) 779-7500.

Dr. Eziokwu's primary practice is Adena Regional Medical Center in Chillicothe, Ohio, part of Adena Health System. Dr. Eziokwu is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Adena Health System. Dmand AI also links Dr. Eziokwu to 4 more hospitals, 7 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eziokwu practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Eziokwu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Eziokwu is licensed in Ohio.

CMS data shows 256 Medicare services from Dr. Eziokwu across 6 procedure codes in 2024, for 171 Medicare patients. Medicare paid $19,238 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 171 Medicare patients who saw Dr. Eziokwu in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eziokwu's median patient age at 73, with 53% women.

In 2024, Dr. Eziokwu wrote 294 Medicare Part D claims for 118 patients. 93% of them were for generic drugs. CMS names the drug for 80 of them, across 5 drugs with 11 or more claims each, at $672 in total drug cost. In 2023, CMS named 19 claims across 1 drug.

Dr. Eziokwu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Eziokwu, published from 2018 to 2019. 2019 was the busiest year, with 2. Dr. Eziokwu's most frequent co-authors are Dana Elizabeth Angelini, MD, Megan Lynn Kruse, MD and Alberto Jose Montero, MD.

CMS Open Payments shows 12 general payments to Dr. Eziokwu from 8 drug and device companies from 2019 to 2025. Education make up the largest share, 57% of the total. Incyte Corporation paid the most, $169.